A Successful Strategy for Estimating the Consumption of Needles and Syringes by Injecting Drug Users in the Czech Republic
DOI:
https://doi.org/10.20882/adicciones.133Keywords:
needle exchange, needles, syringes, injecting equipment, consumption, injecting drug users.Abstract
The objectives were to: (i) estimate the extent of the injecting equipment (IE) provided by needle exchange programs (NEPs) to injecting drug users (IDUs) in the Czech Republic in 2010; (ii) subsequently validate the recent methodology used for data collection by the Czech National Monitoring Centre for Drugs and Drug Addiction (CMC), and (iii) estimate the number of syringes provided to Czech IDUs. A simple document analysis was performed in order to collect data on the production, sale, and consumption of injecting equipment in the Czech Republic in combination with questionnaire screening in the NEPs and 21 brief interviews with key informants. Ten types of IE most commonly used for drug injecting by the Czech drug users were identified. Approximately 5,038,000 pieces of sterile IE were marketed in the Czech Republic in 2010. According to four manufacturers (with a market share of 96%) and with reference to the year 2010, 5,430,694 pieces of sterile IE were provided to Czech injecting drug users (487,694 pieces of IE were sold to IDUs in pharmacies and 5,038,000 pieces of IE were distributed by NEPs in 2010). We compared the amount of IE provided to IDUs as reported to the CMC National registry by NEPs (4,943,000) with that of IE distributed by manufacturers and distributors (5,038,000) in the country in 2010 and found a difference of less than two percent using two different methodologies. This study confirms the accuracy of the data on the amount of IE exchanged as collected by the CMC monitoring system. This study opens up important public health practice and policy-making issues. The methodology of this study may be used in regions where no data collection system is present or where confirmation of the data related to IE is needed.References
Alter, M.J. (1997). The epidemiology of acute and chronic hepatitis C. Clinical Liver Disease, 1, 559-568.
EMCDDA - European Monitoring Centre for Drugs and Drug Addiction (2012). 2012 Annual report on the state of the drugs problem in Europe. Lisbon: EMCDDA.
EMCDDA - European Monitoring Centre for Drugs and Drug Addiction (2011). 2011 Annual report on the state of the drugs problem in Europe. Lisbon: EMCDDA.
EMCDDA - European Monitoring Centre for Drugs and Drug Addiction (2008). Statistical Bulletin 2007. Health and Social Responses. Lisbon: EMCDDA.
Friedman, S. R., de Jong, W., Rossi, D., Touze, G., Rockwell, R., Des Jarlais, D. C., & Elovich, R. (2007). Harm reduction theory: Users’ culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users’ groups. International Journal of Drug Policy,18, 107-117.
Gabrhelík, R. & Miovský, M. (2009). Možnosti a meze současného využití sít˘ˇe lékáren z hlediska jejich participace na nízkoprahových veˇrejnozdravrotních intervencích v rámci adiktologických služeb. Adiktologie, 9, 74-84.
Gabrhelík, R., Miovský, M., & Miovská, L. (2008). Dotazníkový pr°uzkum harm reduction intervencí v lékárnách ˇCeské republiky. Alkoholismus a drogové závislosti, 43, 271-294.
Grund, J. P., Blanken, P., Adriaans, N. F., Kaplan, C. D., Barendregt, C., & Meeuwsen, M. (1992). Reaching the unreached: Targeting hidden IDU populations with clean needles via known user groups. Journal of Psychoactive Drugs, 24, 41-47.
Heller, D. I., Paone, D., Siegler, A., & Karpati, A. (2009). The syringe gap: an assessment of sterile syringe need and acquisition among syringe exchange program participants in New York City. Harm Reduction Journal, 6, 1. doi:10.1186/1477-7517-6-1
IHRA - Harm Reduction International (2012). The Global State of Harm Reduction 2012: Towards an integrated response. London: Harm Reduction International.
Mehta, S. H., Astemborski, J., Kirk, G. D., Strathdee, S. A., Nelson, K. E., Vlahov, D., & Thomas, D. L. (2011). Changes in blood-borne infection risk among injection drug users. Journal of Infectious Diseases, 203, 587-594. doi: 10.1093/infdis/jiq112
Mino, M. & Deren, S. (2004). Disparities in HIV prevention services, infection rates and mortality: a comparison of drug users in Puerto Rico and New York. New York, NY: National Development and Research Institutes.
Mravčík, V. & Zábranský, T. (2001). Dotazníkový pr°uzkum injekčního užívání drog v lékárnách ˇCeské republiky. Adiktologie 1, 10-21.
Mravčík, V., Grohmannová, K., Chomynová, P., Nečas, V., Grolmusová, L., Kiššová, L.,… Jurystová, L. (2012). Annual Report: The Czech Republic – 2011 Drug Situation. Prague: Office of the Government of the Czech Republic.
Mravčík, V., Chomynová, P., Orlíková, B., Škrdlantová, E., Trojáčková, A., Petroš, O.,… Vacek, J. (2007) Annual report. The Czech Republic 2006 Drug Situation. Prague: Office of the Government of the Czech Republic.
Mravčík, V., Korčišová, B., Lejčková, P., Miovská, L., Škrdlantová, E., Petroš, O.,… Vopravil, J. (2004). Výroční zpráva o stavu ve vˇecech drog v ˇCeské republice v roce 2003. Praha: Úˇrad vlády ˇCR.
Mravčík, V., Korčišová, B., Lejčková, P., Miovská, L., Škrdlantová, E., Petroš, O.,… Vopravil, J. (2005). Výroční zpráva o stavu ve vˇecech drog v ˇCeské republice v roce 2004. Prague: Office of the Government of the Czech Republic.
Mravčík, V., Lejčková, P., Orlíková, B., Petrošová, B., Škrdlantová, E., Trojáčková, A.,… Vopravil, J. (2006) Annual Report: The Czech Republic – 2005 Drug Situation. Prague: Office of the Government of the Czech Republic.
Mravčík, V., Pešek, R., Horáková, M., Nečas, V., Chomynová, P., Št’astná, L.,… Koˇnák, T. (2011). Annual Report: The Czech Republic – 2010 Drug Situation. Prague: Office of the Government of the Czech Republic.
Mravčík, V., Pešek, R., Horáková, M., Nečas, V., Škaˇrupová, K., Št’astná, L.,… Zábranský, T. (2010). Annual Report: The Czech Republic – 2009 Drug Situation. Prague: Office of the Government of the Czech Republic.
Mravčík, V., Pešek, R., Škaˇrupová, K., Orlíková, B., Škrdlantová, E., Št’astná, L.,… Vopravil, J. (2009). Annual Report: The Czech Republic – 2008 Drug Situation. Prague: Office of the Government of the Czech Republic.
Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L.J. (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. Lancet, 378, 571-583. doi:10.1016/S0140-6736(11)61097-0
Petroš, O., Mravčík, V., & Korčišová, B. (2005). Spotˇreba drog problémovými uživateli. Adiktologie, 5, 49-59.
Romero-Vallecillos, M., Oviedo-Joekes, E., March-Cerdà, J.C., & Alonso, I.M. (2005). Programas de jeringuillas. Adicciones, 17, 257-275.
Thomas, D. L., Leoutsakas, D., Zabransky, T., & Kumar, M.S. (2011). Hepatitis C in HIV-infected individuals: cure and control, right now. Journal of the International AIDS Society, 14, 22.
Trujols, J., Iraurgi, I., Solà, I., Ballesteros, J., Siñol, N., Batlle, N., & Pérez de los Cobos, J. (2010). Infección por VIH y usuarios de drogas por vía parenteral: Urgencia de la revitalización de los programas de reducción de daños. Adicciones, 22, 135-140.
UNAIDS (2009). HIV Prevention among injecting drug users. Retrieved at http://data.unaids.org/pub/InformationNote/2009/20090518_hiv_prevention_among_idus_final_en.pdf.
WHO - World Health Organization (2007). Interventions to address HIV in prisons: needle and syringe programmes and decontamination strategies. Geneva, Switzerland: WHO Press.
Wodak, A. & McLeod, L. (2008). The role of harm reduction in controlling HIV among injecting drug users. AIDS, 22, S81-92. doi: 10.1097/01.aids.0000327439.20914.33.
